The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 04, 2012

Filed:

Jun. 04, 2007
Applicants:

Rikki Peter Alexander, Slough, GB;

Stuart Bailey, Slough, GB;

Stephen Brand, Dundee, GB;

Daniel Christopher Brookings, Slough, GB;

Julien Alistair Brown, Slough, GB;

Alan Findlay Haughan, Slough, GB;

Natasha Kinsella, Slough, GB;

Christopher Lowe, Slough, GB;

Stephen Robert Mack, Slough, GB;

William Ross Pitt, Slough, GB;

Marianna Dilani Richard, Slough, GB;

Andrew Sharpe, Slough, GB;

Laura Jane Tait, Slough, GB;

Inventors:

Rikki Peter Alexander, Slough, GB;

Stuart Bailey, Slough, GB;

Stephen Brand, Dundee, GB;

Daniel Christopher Brookings, Slough, GB;

Julien Alistair Brown, Slough, GB;

Alan Findlay Haughan, Slough, GB;

Natasha Kinsella, Slough, GB;

Christopher Lowe, Slough, GB;

Stephen Robert Mack, Slough, GB;

William Ross Pitt, Slough, GB;

Marianna Dilani Richard, Slough, GB;

Andrew Sharpe, Slough, GB;

Laura Jane Tait, Slough, GB;

Assignee:

UCB Pharma SA, Brussels, BE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/535 (2006.01);
U.S. Cl.
CPC ...
Abstract

A series of 5,6-dihydro-1-benzothiophen-7(4H)-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.


Find Patent Forward Citations

Loading…